Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Non-Current Assets (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Non-Current Assets for 6 consecutive years, with $5.5 million as the latest value for Q3 2018.

  • Quarterly Non-Current Assets fell 4.96% to $5.5 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $22.5 million through Sep 2018, down 36.11% year-over-year, with the annual reading at $5.8 million for FY2017, 51.41% down from the prior year.
  • Non-Current Assets hit $5.5 million in Q3 2018 for Armata Pharmaceuticals, down from $5.6 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $21.7 million in Q3 2014 to a low of $5.5 million in Q3 2018.
  • Historically, Non-Current Assets has averaged $15.5 million across 5 years, with a median of $21.5 million in 2016.
  • Biggest five-year swings in Non-Current Assets: grew 5.08% in 2014 and later crashed 73.03% in 2017.
  • Year by year, Non-Current Assets stood at $21.6 million in 2014, then decreased by 0.56% to $21.5 million in 2015, then crashed by 44.87% to $11.8 million in 2016, then tumbled by 51.41% to $5.8 million in 2017, then dropped by 4.31% to $5.5 million in 2018.
  • Business Quant data shows Non-Current Assets for ARMP at $5.5 million in Q3 2018, $5.6 million in Q2 2018, and $5.7 million in Q1 2018.